| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.RADONC.2004.10.011 |
| P698 | PubMed publication ID | 15734198 |
| P50 | author | Michael Baumann | Q59959645 |
| Mechthild Krause | Q62451782 | ||
| P2093 | author name string | A Harstrick | |
| C Petersen | |||
| F Hessel | |||
| C Schütze | |||
| N Pimentel | |||
| P433 | issue | 2 | |
| P304 | page(s) | 109-115 | |
| P577 | publication date | 2004-11-25 | |
| P1433 | published in | Radiotherapy and Oncology | Q14251029 |
| P1476 | title | Different classes of EGFR inhibitors may have different potential to improve local tumour control after fractionated irradiation: a study on C225 in FaDu hSCC | |
| P478 | volume | 74 |
| Q39939644 | Augmentation of radiation response by panitumumab in models of upper aerodigestive tract cancer |
| Q37453248 | Cancer stem cells and radiotherapy. |
| Q38849191 | Clinical development of new drug-radiotherapy combinations |
| Q90455060 | Combined external beam radiotherapy with carbon ions and tumor targeting endoradiotherapy |
| Q34740289 | Effect of combined irradiation and EGFR/Erb-B inhibition with BIBW 2992 on proliferation and tumour cure in cell lines and xenografts. |
| Q33353609 | Epidermal growth factor receptor inhibitors for radiotherapy: biological rationale and preclinical results. |
| Q28282037 | Exploring the role of cancer stem cells in radioresistance |
| Q39289085 | Flow cytometric cell-based assay to preselect antibody constructs for radionuclide conjugation. |
| Q36734936 | HER family inhibitors in pancreatic cancer: current status and future directions |
| Q37628728 | Heterogeneity of tumour response to combined radiotherapy and EGFR inhibitors: differences between antibodies and TK inhibitors |
| Q36235732 | Improving external beam radiotherapy by combination with internal irradiation |
| Q39065896 | Isobologram analysis of triple therapies |
| Q34291564 | Lapatinib in combination with radiation diminishes tumor regrowth in HER2+ and basal-like/EGFR+ breast tumor xenografts |
| Q64054036 | Modeling long-term tumor growth and kill after combinations of radiation and radiosensitizing agents |
| Q37676970 | Nuclear EGFR as novel therapeutic target: insights into nuclear translocation and function |
| Q40127407 | Phosphorylation of eIF2alpha is required for mRNA translation inhibition and survival during moderate hypoxia. |
| Q51749302 | Potential of a Cetuximab-based radioimmunotherapy combined with external irradiation manifests in a 3-D cell assay. |
| Q35966191 | Radiosensitization by a novel Bcl-2 and Bcl-XL inhibitor S44563 in small-cell lung cancer |
| Q37368256 | Receptor signaling as a regulatory mechanism of DNA repair |
| Q36219713 | The phosphoinositide 3-kinase signalling pathway as a therapeutic target in squamous cell carcinoma of the head and neck. |
| Q52627703 | The vascular disrupting agent ombrabulin (AVE8062) enhances the efficacy of standard therapies in head and neck squamous cell carcinoma xenograft models. |
| Q54490610 | [Experimental tumor therapy]. |
Search more.